Anthrax in humans and animals

[1]  Jerome Hauer,et al.  Anthrax as a biological weapon, 2002: updated recommendations for management. , 2002, JAMA.

[2]  S. Welkos,et al.  Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen , 1990, Infection and immunity.

[3]  P. Turnbull,et al.  Ecology and epidemiology of anthrax in the Etosha National Park, Namibia. , 1994, The Onderstepoort journal of veterinary research.

[4]  G. Koshi,et al.  Anthrax meningitis, a rare clinical entity. , 1981, The Journal of the Association of Physicians of India.

[5]  A. Kaufmann,et al.  An epizootiologic study of anthrax in Falls County, Texas. , 1977, Journal of the American Veterinary Medical Association.

[6]  The effectiveness and safety of vaccines against human anthrax: a systematic review. , 1998, Vaccine.

[7]  H. Smith,et al.  Non-identity of the phospholipase of Bacillus anthracis with the anthrax toxin. , 1956, Journal of General Microbiology.

[8]  B. Ivins,et al.  Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs , 1997, Infection and immunity.

[9]  H. Lüders,et al.  Comments , 2002, Clinical Neurophysiology.

[10]  J. Melling,et al.  Bacillus anthracis on Gruinard Island , 1981, Nature.

[11]  R. Brookmeyer,et al.  The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak. , 2001, Biostatistics.

[12]  Dm Jones.  A Colour Atlas of Bacillus Species , 1983 .

[13]  M. Meyer,et al.  Anthrax meningitis in Zimbabwe. , 1981, The Central African journal of medicine.

[14]  J. Ezzell,et al.  Familial outbreak of agricultural anthrax in an area of Northern Italy , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  J. Parker,et al.  Rapid Recovery and Identification of Anthrax Bacteria from the Environment , 2000, Annals of the New York Academy of Sciences.

[16]  L. Touqui,et al.  High Bactericidal Efficiency of Type IIA Phospholipase A2 against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin1 , 2004, The Journal of Immunology.

[17]  M. Hugh-jones,et al.  The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.

[18]  H. F. Smyth,et al.  INDUSTRIAL ANTHRAX. , 2022, American journal of public health.

[19]  J. Barnes.  The Development of Anthrax following the Administration of Spores by Inhalation , 1947 .

[20]  S. Welkos.  Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis. , 1991, Microbial pathogenesis.

[21]  George Georgiou,et al.  Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity , 2002, Nature Biotechnology.

[22]  A. Kaufmann,et al.  Woolsorters' disease. An experimental model. , 1971, Archives of pathology.

[23]  U. D. Pienaar.  A second outbreak of anthrax amongst game animals in the Kruger National Park. 5th June to 11th October, 1960. , 1961 .

[24]  R. Bhatnagar,et al.  Anthrax Toxin , 2001, Critical reviews in microbiology.

[25]  Jennifer L. Williams,et al.  Anthrax Postexposure Prophylaxis in Postal Workers, Connecticut, 2001 , 2002, Emerging infectious diseases.

[26]  T. Ellis,et al.  Anthrax in cattle in southern Western Australia. , 1996, Australian veterinary journal.

[27]  T. Popović,et al.  The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. , 2003, The American journal of pathology.

[28]  W. I. Jones,et al.  Anthrax Toxin: Causative Agent in the Death of Rhesus Monkeys , 1962, Science.

[29]  A. G. Wedum.  Defensive aspects of biological warfare. , 1956, Journal of the American Medical Association.

[30]  T. Sirisanthana,et al.  Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis. , 1984, The American journal of tropical medicine and hygiene.

[31]  A. Lucas,et al.  The Capsule of Bacillus anthracis Behaves as a Thymus-Independent Type 2 Antigen , 2004, Infection and Immunity.

[32]  I. Keymer.  Diseases of birds of prey , 1972, Veterinary Record.

[33]  A. Fouet,et al.  Bacillus anthracis cell envelope components. , 2002, Current topics in microbiology and immunology.

[34]  Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. , 2001, MMWR. Morbidity and mortality weekly report.

[35]  J N Woody,et al.  Detection of spores of Bacillus anthracis using the polymerase chain reaction. , 1992, The Journal of infectious diseases.

[36]  L. Price,et al.  Multiple-Locus Variable-Number Tandem Repeat Analysis Reveals Genetic Relationships within Bacillus anthracis , 2000, Journal of bacteriology.

[37]  M. Doğanay,et al.  Serology and anthrax in humans, livestock and Etosha National Park wildlife , 1992, Epidemiology and Infection.

[38]  N. Bergman,et al.  Formation and Composition of the Bacillus anthracis Endospore , 2004, Journal of bacteriology.

[39]  S. Leppla,et al.  A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. , 1989, The Journal of biological chemistry.

[40]  P. Hanna,et al.  Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence , 2004, Molecular microbiology.

[41]  J. Ezzell,et al.  Effects of anthrax toxin components on human neutrophils , 1985, Infection and immunity.

[42]  S. Leppla,et al.  The roles of anthrax toxin in pathogenesis. , 2004, Current opinion in microbiology.

[43]  I. Chu,et al.  An outbreak of human gastrointestinal anthrax. , 1984, Annali dell'Istituto superiore di sanita.

[44]  S. Todd,et al.  Genes of Bacillus cereus and Bacillus anthracis Encoding Proteins of the Exosporium , 2003, Journal of bacteriology.

[45]  S. Plotkin,et al.  An epidemic of inhalation anthrax: the first in the twentieth century. II. Epidemiology. , 1960, American journal of hygiene.

[46]  T. Popović,et al.  Antimicrobial Susceptibility Testing of Bacillus anthracis: Comparison of Results Obtained by Using the National Committee for Clinical Laboratory Standards Broth Microdilution Reference and Etest Agar Gradient Diffusion Methods , 2002, Journal of Clinical Microbiology.

[47]  C. Redmond,et al.  Experimentally assessed public health risks associated with pigs from farms experiencing anthrax , 1997, Veterinary Record.

[48]  Diana Haines,et al.  Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. , 2003, The Journal of clinical investigation.

[49]  T. Ezaki,et al.  Direct detection of Bacillus anthracis DNA in animals by polymerase chain reaction , 1993, Journal of clinical microbiology.

[50]  C. Cefai,et al.  Cowpox can mimic anthrax , 1993, The British journal of dermatology.

[51]  G. S. Woodhead.  The Life of Pasteur , 1902, Edinburgh Medical Journal.

[52]  A. Kadanalı,et al.  Anthrax during pregnancy: case reports and review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  R. Hagen,et al.  Growth characteristics of Bacillus anthracis compared to other Bacillus spp. on the selective nutrient media Anthrax Blood Agar and Cereus Ident Agar. , 2006, Systematic and applied microbiology.

[54]  R. Liddington,et al.  Crystal structure of the anthrax toxin protective antigen , 1997, Nature.

[55]  T. Koehler,et al.  Early Bacillus anthracis–macrophage interactions: intracellular survival and escape , 2000 .

[56]  A. Shafferman,et al.  Attenuated Nontoxinogenic and Nonencapsulated Recombinant Bacillus anthracis Spore Vaccines Protect against Anthrax , 2000, Infection and Immunity.

[57]  B. Ivins,et al.  The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. , 1998, Archives of pathology & laboratory medicine.

[58]  M. Turell,et al.  Mechanical transmission of Bacillus anthracis by stable flies (Stomoxys calcitrans) and mosquitoes (Aedes aegypti and Aedes taeniorhynchus) , 1987, Infection and immunity.

[59]  M. Doğanay,et al.  Antimicrobial susceptibility of Bacillus anthracis. , 1991, Scandinavian journal of infectious diseases.

[60]  L. Braack,et al.  Feeding habits and flight range of blow-flies (Chrysomyia spp.) in relation to anthrax transmission in the Kruger National Park, South Africa. , 1990, The Onderstepoort journal of veterinary research.

[61]  S. Welkos,et al.  Differences in susceptibility of inbred mice to Bacillus anthracis , 1986, Infection and immunity.

[62]  G. Meynell,et al.  THE ROLES OF SERUM AND CARBON DIOXIDE IN CAPSULE FORMATION BY BACILLUS ANTHRACIS. , 1964, Journal of general microbiology.

[63]  D. L. Lundgren,et al.  Intracutaneous anthrax infection in wild rodents. , 1957, Journal of Infectious Diseases.

[64]  G. Wright,et al.  Immunization of cattle against experimental anthrax with alum-precipitated protective antigen or spore vaccine. , 1957, American journal of veterinary research.

[65]  D H Walker,et al.  Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Welkos,et al.  The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. , 2004, Microbial pathogenesis.

[67]  C. Practice.  Management of asymptomatic pregnant or lactating women exposed to anthrax. , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[68]  D. Mckendrick.  Anthrax and its transmission to humans. , 1980, The Central African journal of medicine.

[69]  V. De Vos,et al.  The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park. , 1991, The Onderstepoort journal of veterinary research.

[70]  Ames,et al.  A bacteriolytic agent that detects and kills Bacillus anthracis , 2022 .

[71]  A. Casadevall.  Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons , 2002, Emerging infectious diseases.

[72]  S. Leppla,et al.  Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity , 2004, Medical Microbiology and Immunology.

[73]  S. Parks,et al.  Airborne movement of anthrax spores from carcass sites in the Etosha National Park, Namibia , 1998, Journal of applied microbiology.

[74]  C. J. Duggleby,et al.  Bacillus anthracis but not always anthrax. , 1992, The Journal of applied bacteriology.

[75]  C. B. Thorne,et al.  Demonstration of a capsule plasmid in Bacillus anthracis , 1985, Infection and immunity.

[76]  T. Popović,et al.  Pathology and pathogenesis of bioterrorism-related inhalational anthrax. , 2003, The American journal of pathology.

[77]  Ala I Sharara,et al.  Endemic Gastrointestinal Anthrax in 1960s Lebanon: Clinical Manifestations and Surgical Findings , 2003, Emerging infectious diseases.

[78]  M. Mock,et al.  Contribution of individual toxin components to virulence of Bacillus anthracis , 1991, Infection and immunity.

[79]  R. Jackson.  The Introduction into Great Britain of Anthrax Infection by Means of Products. of Animal Origin. , 1930 .

[80]  M. Zelle,et al.  Respiratory pathogenicity of Bacillus anthracis spores; changes in pathogenicity due to nutritional modifications. , 1946, The Journal of infectious diseases.

[81]  M. Hugh-jones,et al.  Bacillus anthracis Virulence in Guinea Pigs Vaccinated with Anthrax Vaccine Adsorbed Is Linked to Plasmid Quantities and Clonality , 2003, Journal of Clinical Microbiology.

[82]  J. Ezzell,et al.  Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.

[83]  A. Friedlander,et al.  Anthrax capsule vaccine protects against experimental infection. , 2004, Vaccine.

[84]  R. Bull,et al.  Specificity of an immunochromatographic test for anthrax. , 2004, Australian veterinary journal.

[85]  J. Kirby.  Anthrax Lethal Toxin Induces Human Endothelial Cell Apoptosis , 2004, Infection and Immunity.

[86]  J. Charney,et al.  MANGANESE AS AN ESSENTIAL ELEMENT FOR SPORULATION IN THE GENUS BACILLUS , 1951, Journal of bacteriology.

[87]  J. Vaissaire,et al.  Antibiotic Susceptibilities of 96 Isolates of Bacillus anthracis Isolated in France between 1994 and 2000 , 2002, Antimicrobial Agents and Chemotherapy.

[88]  E. McCloy.  Lysogenicity and immunity to Bacillus phage W. , 1958, Journal of general microbiology.

[89]  J. Ezzell,et al.  Immunological analysis of cell-associated antigens of Bacillus anthracis , 1988, Infection and immunity.

[90]  M. Mock,et al.  Fate of germinated Bacillus anthracis spores in primary murine macrophages , 2001, Molecular microbiology.

[91]  C. Leonard,et al.  POLYGLUTAMIC ACID SYNTHESIS BY CELL-FREE EXTRACTS OF BACILLUS LICHENIFORMIS. , 1963, Biochimica et biophysica acta.

[92]  D. Kehoe.  Anthrax in South Africa. , 2022 .

[93]  G. Patra,et al.  Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pXO1 and pXO2 and chromosomal DNA. , 1996, FEMS microbiology letters.

[94]  J. Peterson,et al.  Human Monoclonal Anti-Protective Antigen Antibody Completely Protects Rabbits and Is Synergistic with Ciprofloxacin in Protecting Mice and Guinea Pigs against Inhalation Anthrax , 2006, Infection and Immunity.

[95]  M. Sterne.  The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis , 1939 .

[96]  G. Sternbach.  The history of anthrax. , 2003, The Journal of emergency medicine.

[97]  H. Smith,et al.  Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity. , 1956, The Biochemical journal.

[98]  H. Smith,et al.  The polysaccharide from Bacillus anthracis grown in vivo. , 1956, The Biochemical journal.

[99]  S. Plotkin,et al.  Serologic testing for anthrax antibodies in workers in a goat hair processing mill. , 1960, American journal of hygiene.

[100]  M. Mock,et al.  The incompatibility between the PlcR‐ and AtxA‐controlled regulons may have selected a nonsense mutation in Bacillus anthracis , 2001, Molecular microbiology.

[101]  Christophe Boesch,et al.  Anthrax kills wild chimpanzees in a tropical rainforest , 2004, Nature.

[102]  Nikos Kyrpides,et al.  Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis , 2003, Nature.

[103]  K. Bush,et al.  Effective Antimicrobial Regimens for Use in Humans for Therapy of Bacillus anthracis Infections and Postexposure Prophylaxis , 2005, Antimicrobial Agents and Chemotherapy.

[104]  Brian Balmer,et al.  Chemical and Biological Warfare and Defence, 1945-90 , 1999 .

[105]  W S GOCHENOUR,et al.  PATHOLOGY OF EXPERIMENTAL RESPIRATORY ANTHRAX IN MACACA MULATTA. , 1963, British journal of experimental pathology.

[106]  C. Gates,et al.  Investigation, control and epizootiology of anthrax in a geographically isolated, free-roaming bison population in northern Canada. , 1995, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[107]  H. Srinivasa,et al.  Intestinal anthrax with bacteriological investigations. , 1985, The Journal of infectious diseases.

[108]  E. Meynell.  REVERTING AND NON-REVERTING ROUGH VARIANTS OF BACILLUS ANTHRACIS. , 1963, Journal of general microbiology.

[109]  H. F. Smyth.  ANTHRAX-A CONTINUING AND PROBABLY INCREASING HAZARD OF INDUSTRY. , 1924, American journal of public health.

[110]  L. Weinstein.  The Prophylaxis of Experimental Anthrax Infection with Various Hormone Preparations * , 1939, The Yale journal of biology and medicine.

[111]  S. Welkos,et al.  Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. , 1989, Microbial pathogenesis.

[112]  P. E. Granum,et al.  The adhesion of Bacillus cereus spores to epithelial cells might be an additional virulence mechanism. , 1998, International journal of food microbiology.

[113]  David M. Bell,et al.  Clinical Issues in the Prophylaxis, Diagnosis, and Treatment of Anthrax , 2002, Emerging infectious diseases.

[114]  M. Hugh-jones,et al.  PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[115]  C. B. Thorne,et al.  Synthesis of glutamic acid and glutamyl polypeptide by Bacillus anthracis. I. Formation of glutamic acid by transamination. , 1950, Journal of bacteriology.

[116]  A. Athamna,et al.  In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. , 2004, The Journal of antimicrobial chemotherapy.

[117]  C. J. Duggleby,et al.  The development and assessment of DNA and oligonucleotide probes for the specific detection of Bacillus anthracis. , 1993, The Journal of applied bacteriology.

[118]  J C Davies,et al.  A major epidemic of anthrax in Zimbabwe. The experience at the Beatrice Road Infectious Diseases Hospital, Harare. , 1985, The Central African journal of medicine.

[119]  C. Turnbough,et al.  Identification of the Immunodominant Protein and Other Proteins of the Bacillus anthracis Exosporium , 2003, Journal of bacteriology.

[120]  H. Nissen,et al.  Enterotoxin from Bacillus cereus: production and biochemical characterization , 1993 .

[121]  C. Weis,et al.  Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office. , 2002, JAMA.

[122]  Age as a Risk Factor for Cutaneous Human Anthrax: Evidence from Haiti, 1973–1974 , 2002, Emerging infectious diseases.

[123]  G. V. Van Ness,et al.  Soils of the United States favorable for anthrax. , 1956, Journal of the American Veterinary Medical Association.

[124]  R. Gainer,et al.  Aspects of the epidemiology of anthrax in Wood Buffalo National Park and environs. , 1989, The Canadian veterinary journal = La revue veterinaire canadienne.

[125]  R. Hewlett.  Diseases of Sheep , 1906, Nature.

[126]  L. Lutwick,et al.  Inhalational anthrax , 2020, Current infectious disease reports.

[127]  W. I. Jones,et al.  Value of field data for extrapolation in anthrax. , 1967, Federation proceedings.

[128]  P. J. Kadull,et al.  CUTANEOUS ANTHRAX: Report of Twenty-Five Cases , 1946 .

[129]  R. Walker,et al.  Intestinal barriers to bacteria and their toxins. , 1990, Annual review of medicine.

[130]  Dori B. Reissman,et al.  One-year health assessment of adult survivors of Bacillus anthracis infection. , 2004, JAMA.

[131]  I. Phillips.  Cowan and Steel's Manual for the Identification of Medical Bacteria , 1993 .

[132]  J. Melling,et al.  Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity , 1986, Infection and immunity.

[133]  G L Andersen,et al.  Identification of a region of genetic variability among Bacillus anthracis strains and related species , 1996, Journal of bacteriology.

[134]  W. Beyer,et al.  Polymerase chain reaction‐ELISA to detect Bacillus anthracis from soil samples—limitations of present published primers , 1999, Journal of applied microbiology.

[135]  D. Dragon,et al.  Natural Dissemination of Bacillus anthracis Spores in Northern Canada , 2005, Applied and Environmental Microbiology.

[136]  B. Simmons,et al.  Guideline for isolation precautions in hospitals , 1984, American Journal of Infection Control.

[137]  A. Fouet,et al.  Bacillus anthracis CapD, belonging to the γ‐glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan , 2005, Molecular microbiology.

[138]  L. Price,et al.  Bacillus anthracis Diversity in Kruger National Park , 2000, Journal of Clinical Microbiology.

[139]  K D Paull,et al.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.

[140]  A. Stepanov,et al.  Development of novel vaccines against anthrax in man. , 1996, Journal of biotechnology.

[141]  G. Meynell,et al.  The biosynthesis of poly d-glutamic acid, the capsular material of Bacillus anthracis. , 1966, Journal of general microbiology.

[142]  S. Leppla,et al.  Protection against Anthrax Lethal Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal Factor Protein , 2001, Infection and Immunity.

[143]  H. Smith,et al.  The chemical basis of the virulence of Bacillus anthracis. III. The role of the terminal bacteraemia in death of guinea-pigs from anthrax. , 1955, British journal of experimental pathology.

[144]  G. Meynell,et al.  Inheritance of capsule and the manner of cell-wall formation in Bacillus anthracis. , 1965, Journal of general microbiology.

[145]  N. A. Logan,et al.  Identification of Bacillus strains using the API system. , 1984, Journal of general microbiology.

[146]  M. T. Musa,et al.  Anthrax in humans and camels in the Sudan with reference to the disease in the country. , 1993, Revue d'elevage et de medecine veterinaire des pays tropicaux.

[147]  A. Bohm,et al.  Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin , 2002, Nature.

[148]  Field Evaluation of a Human Anthrax Vaccine. , 1962, American journal of public health and the nation's health.

[149]  M. Sterne.  Avirulent anthrax vaccine. , 1946, The Onderstepoort journal of veterinary science and animal industry.

[150]  B. Elewski,et al.  Cutaneous anthrax management algorithm. , 2002, Journal of the American Academy of Dermatology.

[151]  S. Cinti,et al.  Bacillus Anthracis as an Agent of Bioterrorism: A Review Emphasizing Surgical Treatment , 2002, Annals of surgery.

[152]  J. M. Ross.  The pathogenesis of anthrax following the administration of spores by the respiratory route , 1957 .

[153]  J. Shiloach,et al.  Poly(γ-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: A potential addition to the anthrax vaccine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[154]  Elizabeth R. Zell,et al.  Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence , 2002, Emerging infectious diseases.

[155]  M. Sterne.  The effects of different carbon dioxide concentrations on the growth of virulent anthrax strains : pathogenicity and immunity tests on guinea pigs and sheep with anthrax variants derived from virulent strains , 1937 .

[156]  John Quackenbush,et al.  Murine Macrophage Transcriptional Responses to Bacillus anthracis Infection and Intoxication , 2005, Infection and Immunity.

[157]  C. Gleiser.  Pathology of anthrax infection in animal hosts. , 1967, Federation proceedings.

[158]  D. Nalin,et al.  Survival of a patient with intestinal anthrax. , 1977, The American journal of medicine.

[159]  W. S. Gochenour,et al.  Pulmonary lesions in dogs and pigs exposed to a cloud of anthrax spores. , 1968, Journal of comparative pathology.

[160]  B. Stocker.  Topley and Wilson's Principles of Bacteriology, Virology and Immunity , 1976 .

[161]  B. Knight,et al.  A comparative survey of the nutrition and physiology of mesophilic species in the genus Bacillus. , 1950, Journal of general microbiology.

[162]  David D. Williams,et al.  Surface Layer Protein EA1 Is Not a Component of Bacillus anthracis Spores but Is a Persistent Contaminant in Spore Preparations , 2004, Journal of bacteriology.

[163]  J. Ezzell,et al.  Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. , 1988, The American journal of tropical medicine and hygiene.

[164]  T. Koehler,et al.  Characterization of Anthrolysin O, the Bacillus anthracis Cholesterol-Dependent Cytolysin , 2003, Infection and Immunity.

[165]  H. Chu.  Variation of Bacillus anthracis with special reference to the non-capsulated avirulent variant , 1952, Epidemiology and Infection.

[166]  M. Hugh-jones,et al.  Anthrax and wildlife. , 2002, Revue scientifique et technique.

[167]  R Lamb,et al.  Anthrax. , 1973, Red Book (2018).

[168]  D. W. Henderson,et al.  Observations on the prophylaxis of experimental pulmonary anthrax in the monkey , 1956, Journal of Hygiene.

[169]  Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[170]  E. Hewlett,et al.  Anthrax Toxin Components Stimulate Chemotaxis of Human Polymorphonuclear Neutrophils , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[171]  G. Patra,et al.  The Ba813 chromosomal DNA sequence effectively traces the whole Bacillus anthracis community , 1999, Journal of applied microbiology.

[172]  A. Moir,et al.  Identification of proteins in the exosporium of Bacillus anthracis. , 2004, Microbiology.

[173]  Toshiaki Maruyama,et al.  Human antibodies from immunized donors are protective against anthrax toxin in vivo , 2003, Nature Biotechnology.

[174]  A. Bahrami.  THE TREATMENT OF ANTHRAX , 1932, Canadian Medical Association journal.

[175]  J. W. Thomas,et al.  A Die-off in White-Tailed Deer of the Central Mineral Region of Texas , 1965 .

[176]  H. Smith,et al.  Observations on Experimental Anthrax: Demonstration of a Specific Lethal Factor produced in vivo by Bacillus anthracis , 1954, Nature.

[177]  R. Bull,et al.  Vaccine-induced protection against anthrax in cheetah (Acinonyx jubatus) and black rhinoceros (Diceros bicornis). , 2004, Vaccine.

[178]  W. Albrink,et al.  Experimental inhalation anthrax in the chimpanzee. , 1959, The American journal of pathology.

[179]  S. Welkos,et al.  Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys , 1996 .

[180]  Fei Wang,et al.  Journal of Immune Based Therapies and Vaccines Human Anti-anthrax Protective Antigen Neutralizing Monoclonal Antibodies Derived from Donors Vaccinated with Anthrax Vaccine Adsorbed , 2022 .

[181]  L. Makala,et al.  Anthrax in wildlife in the Luangwa Valley, Zambia , 1991, Veterinary Record.

[182]  John A. Young,et al.  Identification of the cellular receptor for anthrax toxin , 2001, Nature.

[183]  Seth Krantz,et al.  Discussion , 1998, Neuroscience.

[184]  M Hugh-Jones,et al.  Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers , 1997, Journal of bacteriology.

[185]  Douglas J Lanska.  Anthrax meningoencephalitis , 2002, Neurology.

[186]  Michael Babin,et al.  A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge , 2005, Infection and Immunity.

[187]  L. Baillie,et al.  Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. , 1998, Vaccine.

[188]  B. Elkin,et al.  An Overview of Early Anthrax Outbreaks in Northern Canada: Field Reports of the Health of Animals Branch, Agriculture Canada, 1962-71 , 2001 .

[189]  T. Koehler.  Bacillus anthracis genetics and virulence gene regulation. , 2002, Current topics in microbiology and immunology.

[190]  Philip S. Brachman,et al.  Bacillus anthracis aerosols in goat hair processing mills. , 1960, American journal of hygiene.

[191]  Tanja Popovic,et al.  Bacillus anthracis Aerosolization Associated with a Contaminated Mail Sorting Machine , 2002, Emerging infectious diseases.

[192]  R. Titball,et al.  Factors affecting the germination of spores of Bacillus anthracis. , 1987, The Journal of applied bacteriology.

[193]  L. Willoughby,et al.  AN ANTHRAX OUTBREAK AFFECTING MAN AND BUFFALO IN THE NORTHWEST TERRITORIES. , 1964, Medical services journal, Canada.

[194]  T. Koehler,et al.  β-Lactamase Genes of the Penicillin-Susceptible Bacillus anthracis Sterne Strain , 2003, Journal of bacteriology.

[195]  Donald J. Reasoner,et al.  Boiling and Bacillus Spores , 2004, Emerging infectious diseases.

[196]  M. N. Jones,et al.  Evaluation of the Biolog system for the identification of Bacillus anthracis , 1995, Letters in applied microbiology.

[197]  D. Acosta,et al.  On the role of macrophages in anthrax. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[198]  H. M. Darlow,et al.  Anthrax in the Gambia: an epidemiological study , 1975, British medical journal.

[199]  M. Doğanay,et al.  A case of cutaneous anthrax with toxaemic shock , 1987, The British journal of dermatology.

[200]  D. Lacy,et al.  Structure and function of anthrax toxin. , 2002, Current topics in microbiology and immunology.

[201]  Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. , 2001, MMWR. Morbidity and mortality weekly report.

[202]  W. I. Jones,et al.  SUCCESSFUL TREATMENT OF RHESUS MONKEYS FOR SEPTICEMIA ANTHRAX. , 1964, Antimicrobial agents and chemotherapy.

[203]  X. Liang,et al.  Identification of Bacillus anthracis strains in China , 1999, Journal of applied microbiology.

[204]  M. Broster,et al.  Formaldehyde Solution Effectively Inactivates Spores of Bacillus anthracis on the Scottish Island of Gruinard , 1994, Applied and environmental microbiology.

[205]  B. Elkin,et al.  A review of anthrax in Canada and implications for research on the disease in northern bison , 1999, Journal of applied microbiology.

[206]  Felicia N. Sutton,et al.  MICs of Selected Antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a Range of Clinical and Environmental Sources as Determined by the Etest , 2004, Journal of Clinical Microbiology.

[207]  J. Frean,et al.  Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide. , 2003, The Journal of antimicrobial chemotherapy.

[208]  M. Mock,et al.  The S‐layer homology domain as a means for anchoring heterologous proteins on the cell surface of Bacillus anthracis , 1999, Journal of applied microbiology.

[209]  S. Popov,et al.  Anaerobic induction of Bacillus anthracis hemolytic activity. , 2003, Biochemical and biophysical research communications.

[210]  Marcus B. Jones,et al.  Exogenous Gamma and Alpha/Beta Interferon Rescues Human Macrophages from Cell Death Induced by Bacillus anthracis , 2004, Infection and Immunity.

[211]  W. Bell,et al.  Pulmonary anthrax in cattle , 1977, Veterinary Record.

[212]  Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. , 2001, MMWR. Morbidity and mortality weekly report.

[213]  A. Friedlander,et al.  From the Centers for Disease Control and Prevention. Human ingestion of Bacillus anthracis-contaminated meat--Minnesota, August 2000. , 2000, JAMA.

[214]  R. Lee.  The microbiology of drinking water. , 1991, Medical laboratory sciences.

[215]  H. Ellerbrok,et al.  Rapid and sensitive identification of pathogenic and apathogenic Bacillus anthracis by real-time PCR. , 2002, FEMS microbiology letters.

[216]  A. Friedlander,et al.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. , 1986, The Journal of biological chemistry.

[217]  D. Robertson,et al.  Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. , 1989, Gene.

[218]  S. Welkos,et al.  Roles of Macrophages and Neutrophils in the Early Host Response to Bacillus anthracis Spores in a Mouse Model of Infection , 2006, Infection and Immunity.

[219]  W. J. Cromartie,et al.  Studies on infection with Bacillus anthracis. , 1947, The Journal of infectious diseases.

[220]  G. V. Van Ness.  Ecology of anthrax. , 1971, Science.

[221]  A. Eisenstark,et al.  PHAGE ISOLATED FROM LYSOGENIC BACILLUS ANTHRACIS , 1963, Journal of bacteriology.

[222]  E. Geissler.  Biological warfare activities in Germany, 1923-45 , 1999 .

[223]  M. Mock,et al.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. , 2000, The Biochemical journal.

[224]  A. Corner.  Textbook of the Special Pathological Anatomy of Domestic Animals , 1968 .

[225]  C. E. Fuller,et al.  Anthrax in Louisiana, 1971: epizootiologic study. , 1973, Journal of the American Veterinary Medical Association.

[226]  M. Mock,et al.  Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. , 1998, Biochemical and biophysical research communications.

[227]  A. Edginton.  An outbreak of anthrax in pigs: a practitioner's account , 1990, Veterinary Record.

[228]  W. Albrink.  Pathogenesis of inhalation anthrax. , 1961, Bacteriological reviews.

[229]  D. Lyon.  An outbreak of anthrax at the Chester Zoological Gardens , 1973, Veterinary Record.

[230]  E. Brown,et al.  Specific identification of Bacillus anthracis by means of a variant bacteriophage. , 1955, The Journal of infectious diseases.

[231]  T. Koehler,et al.  Bacillus anthracis Multiplication, Persistence, and Genetic Exchange in the Rhizosphere of Grass Plants , 2006, Applied and Environmental Microbiology.

[232]  M. Turner.  Anthrax in humans in Zimbabwe. , 1980, The Central African journal of medicine.

[233]  M. Onerci,et al.  [Oropharyngeal anthrax]. , 1993, Laryngo-Rhino-Otologie.

[234]  J. Ezzell,et al.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin , 1984, Infection and immunity.

[235]  T. Reif,et al.  Identification of capsule-forming Bacillus anthracis spores with the PCR and a novel dual-probe hybridization format , 1994, Applied and environmental microbiology.

[236]  J I Blenkharn,et al.  Emission of viable bacteria in the exhaust flue gases from a hospital incinerator. , 1989, The Journal of hospital infection.

[237]  S. Eremin,et al.  [Contribution of determinants, located in Bacillus anthracis chromosomes, in realizing the pathogenic properties of the pathogen]. , 1999, Molecular Genetics Microbiology and Virology (Russian version).

[238]  M. Hugh-jones,et al.  Characterization of the variable-number tandem repeats in vrrA from different Bacillus anthracis isolates , 1997, Applied and environmental microbiology.

[239]  Tanja Popovic,et al.  Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings , 2002, Emerging infectious diseases.

[240]  A Watson,et al.  Information on which to base assessments of risk from environments contaminated with anthrax spores , 1994, Epidemiology and Infection.

[241]  A. Campbell,et al.  Monoclonal antibodies against spore antigens of Bacillus anthracis. , 1988, FEMS microbiology immunology.

[242]  S. Makino,et al.  Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis , 1989, Journal of bacteriology.

[243]  M. Sterne.  Variation in Bacillus anthracis , 1937 .

[244]  Jadwiga Bienkowska,et al.  Crystal structure of the anthrax lethal factor , 2001, Nature.

[245]  P. Sylvestre,et al.  Isolation of a specific chromosomic DNA sequence of Bacillus anthracis and its possible use in diagnosis. , 1996, FEMS immunology and medical microbiology.

[246]  J. Wilson,et al.  ISOLATION OF BACILLUS ANTHRACIS FROM SOIL STORED 60 YEARS , 1964, Journal of Bacteriology.

[247]  R. Hewson,et al.  Protection conferred by microbially-supplemented UK and purified PA vaccines , 1990 .

[248]  B. Corfe,et al.  Alanine germination receptors of Bacillus subtailis , 1996, Letters in applied microbiology.

[249]  H. Jaffe.  Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices. , 2001, Journal of toxicology. Clinical toxicology.

[250]  M. Mock,et al.  Germination of Bacillus anthracis spores within alveolar macrophages , 1999, Molecular microbiology.

[251]  C. P. Quinn,et al.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.

[252]  Gina Pugliese,et al.  Anthrax as a Biological Weapon: Medical and Public Health Management , 1999 .

[253]  T. Sirisanthana,et al.  Anthrax of the Gastrointestinal Tract , 2002, Emerging infectious diseases.

[254]  Davies Jc,et al.  A major epidemic of anthrax in Zimbabwe. , 1982 .

[255]  K. Ruoff,et al.  Bioterrorism: Implications for the Clinical Microbiologist , 2001, Clinical Microbiology Reviews.

[256]  John A. Young,et al.  Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[257]  Anders Sjöstedt,et al.  Detection of Bacillus anthracis spores in soil by PCR , 1997 .

[258]  Y. Hachisuka.  Germination of B. anthracis spores in the peritoneal cavity of rats and establishment of anthrax. , 1969, Japanese journal of microbiology.

[259]  I. Lindberg,et al.  Protection against Anthrax Toxemia by Hexa-d-Arginine In Vitro and In Vivo , 2004, Infection and Immunity.

[260]  R. Bull,et al.  Heat activation/shock temperatures for Bacillus anthracis spores and the issue of spore plate counts versus true numbers of spores. , 2007, Journal of microbiological methods.

[261]  J. E. Bowen.  Factors affecting conventional and molecular detection of Bacillus anthracis in the environment and the stability of B. anthracis identification plasmids PX01 and PX02 in vitro , 2000 .

[262]  S. Welkos,et al.  Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals , 1991, Infection and immunity.

[263]  P. Sylvestre,et al.  A collagen‐like surface glycoprotein is a structural component of the Bacillus anthracis exosporium , 2002, Molecular microbiology.

[264]  M. Hugh-jones,et al.  Antimicrobial Susceptibilities of Diverse Bacillus anthracis Isolates , 2002, Antimicrobial Agents and Chemotherapy.

[265]  E. E. Punskiĭ,et al.  [Role of camels in epidemiology of anthrax]. , 1968, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.

[266]  M. Doğanay,et al.  Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. , 2003, International journal of antimicrobial agents.

[267]  S. Welkos,et al.  In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. , 2002, Journal of medical microbiology.

[268]  M. Mock,et al.  A plasmid‐encoded regulator couples the synthesis of toxins and surface structures in Bacillus anthracis , 2003, Molecular microbiology.

[269]  M. Sterne,et al.  INDUCTION OF MOTILITY AND CAPSULATION IN BACILLUS ANTHRACIS , 1957, Journal of bacteriology.

[270]  S. Hilsenbeck,et al.  atxA Controls Bacillus anthracis Capsule Synthesis via acpA and a Newly Discovered Regulator, acpB , 2004, Journal of bacteriology.

[271]  J. Melling,et al.  Identification of Bacillus anthracis by API tests. , 1985, Journal of medical microbiology.

[272]  B. Ivins,et al.  Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. , 1996, Vaccine.

[273]  H. Chu,et al.  The Egg-Yolk Reaction of Aerobic Sporing Bacilli , 1948 .

[274]  A. L. Fernelius.  COMPARISON OF TWO HEAT-SHOCK METHODS AND A PHENOL TREATMENT METHOD FOR DETERMINING GERMINATION RATES OF SPORES OF BACILLUS ANTHRACIS , 1960, Journal of bacteriology.

[275]  Lilah M. Besser,et al.  Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen , 2002, Emerging infectious diseases.

[276]  L. Grummer-Strawn,et al.  Adherence to Antimicrobial Inhalational Anthrax Prophylaxis among Postal Workers, Washington, D.C., 2001 , 2002, Emerging infectious diseases.

[277]  E. Powell,et al.  A selective medium for Bacillus anthracis. , 1951, Journal of general microbiology.

[278]  J. Widdicombe,et al.  The role of the lymphatic system in the pathogenesis of anthrax. , 1956, British journal of experimental pathology.

[279]  C. Gibbs,et al.  Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[280]  J. Melling,et al.  Decontamination of Bacillus anthracis on Gruinard Island? , 1983, Nature.

[281]  F. Clark,et al.  Aerobic sporeforming bacteria , 1952 .

[282]  Suzanne M. Brandt,et al.  mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[283]  E. Rubinstein,et al.  Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern. , 1997, Vaccine.

[284]  W. Greenfield.  Lectures on Some of the Recent Investigations into the Pathology of Infective and Contagious Diseases , 1880, The Archives of comparative medicine and surgery.

[285]  P. Turnbull.  Current status of immunization against anthrax: old vaccines may be here to stay for a while. , 2000, Current opinion in infectious diseases.

[286]  A. Lucas,et al.  Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate. , 2004, FEMS immunology and medical microbiology.

[287]  R. Pike,et al.  CONTINUING IMPORTANCE OF LABORATORY-ACQUIRED INFECTIONS. , 1965, American journal of public health and the nation's health.

[288]  M. Mock,et al.  Bacillus anthracis surface: capsule and S‐layer , 1999, Journal of applied microbiology.

[289]  L. Baillie,et al.  Characterisation of the immune response to the UK human anthrax vaccine. , 2003, FEMS immunology and medical microbiology.

[290]  P. Glöckner,et al.  A nested PCR method for the detection of Bacillus anthracis in environmental samples collected from former tannery sites. , 1995, Microbiological research.

[291]  J. Ezzell,et al.  Serum protease cleavage of Bacillus anthracis protective antigen. , 1992, Journal of general microbiology.

[292]  S. Salzberg,et al.  The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria , 2003, Nature.

[293]  S. Banks,et al.  Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. , 2005, The Journal of infectious diseases.

[294]  P. Keim,et al.  Bacillus anthracis evolution and epidemiology. , 2002, Current topics in microbiology and immunology.

[295]  F. Dalldorf,et al.  The pathogenesis of the lethal effect of anthrax toxin in the rat. , 1966, The Journal of infectious diseases.

[296]  K. D. Balogh,et al.  Anthrax control and research, with special reference to national programme development in Africa: memorandum from a WHO meeting. , 1994, Bulletin of the World Health Organization.

[297]  Kyung-Soo Inn,et al.  An Anthrax Lethal Factor-Neutralizing Monoclonal Antibody Protects Rats before and after Challenge with Anthrax Toxin , 2005, Infection and Immunity.

[298]  H. Devlin,et al.  Immunizing activity of alum-precipitated protective antigen of Bacillus anthracis in cattle, sheep, and swine. , 1956, American journal of veterinary research.

[299]  V. Balraj,et al.  An outbreak of anthrax meningoencephalitis. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[300]  M. Johns,et al.  Improved methods for the detection of Bacillus anthracis spores by the polymerase chain reaction , 1994 .

[301]  S. Hilsenbeck,et al.  Global Effects of Virulence Gene Regulators in a Bacillus anthracis Strain with Both Virulence Plasmids , 2003, Infection and Immunity.